Legal Representation
Attorney
Michelle Rosenberg
USPTO Deadlines
Application History
10 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 12, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Jun 10, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Nov 7, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 12, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 12, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 23, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 7, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 4, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 6, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 25, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Testing, research, or development of pharmaceutical and biotechnological preparations for cell and gene therapy; product research, development and testing of pharmaceutical and biotechnological preparations for cell and gene therapy for others; Platform as a Service (PaaS) services featuring computer software platforms for developing products and processes in the fields of cell and gene therapy, for manufacturing cell and gene therapy products, and for commercializing cell and gene therapy products and processes
Classification
International Classes
042